Albert Manero

Dr. Albert Manero

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
AMAlbert Manero
Albert Manero
Peter SmithPeter Smith
Peter Smith
JSJohn Sparkman
John Sparkman
MDMatt Dombrowski
Matt Dombrowski
DCDominique Courbin
Dominique Courbin
ACAlbert Chi
Albert Chi
There is an interesting and long history of prostheses designed for those with upper-limb difference, and yet issues still persist that have not yet been solved. Prosthesis needs for children are particularly complex, due in part to their growth rates. Access to a device can have a significant impact on a child’s psychosocial development. Often, devices supporting both cosmetic form and user function are not accessible to children due to high costs, insurance policies, medical availability, and their perceived durability and complexity of control. These challenges have encouraged a grassroots effort globally to offer a viable solution for the millions of people living with limb difference around the world. The innovative application of 3D printing for customizable and user-specific hardware has led to open-source Do It Yourself “DIY” production of assistive devices, having an incredible impact globally for families with little recourse. This paper examines new research and development of prostheses by the maker community and nonprofit organizations, as well as a novel case study exploring the development of technology and the training methods available. These design efforts are discussed further in the context of the medical regulatory framework in the United States and highlight new associated clinical studies designed to measure the quality of life impact of such devices.

AMAlbert Manero
Albert Manero
Peter SmithPeter Smith
Peter Smith
AKAmanda Koontz
Amanda Koontz
MDMatt Dombrowski
Matt Dombrowski
JSJohn Sparkman
John Sparkman
ACAlbert Chi
Albert Chi
The SARS-CoV-2 (COVID-19) pandemic has provided a unique set of global supply chain limitations with an exponentially growing surge of patients requiring care. The needs for Personal Protective Equipment (PPE) for hospital staff and doctors have been overwhelming, even just to rule out patients not infected. High demand for traditionally manufactured devices, challenged by global demand and limited production, has resulted in a call for additive manufactured (3D printed) equipment to fill the gap between traditional manufacturing cycles. This method has the unique ability to pivot in real time, while traditional manufacturing may take months to change production runs. 3D printing has been used to produce a variety of equipment for hospitals including face shields, masks, and even ventilator components to handle the surge. This type of rapid, crowd sourced, design and production resulted in new challenges for regulation, liability, and distribution. This manuscript reviews these challenges and successes of additive manufacturing and provides a forward plan for hospitals to consider for future surge events. Recommendations: To accommodate future surges, hospitals and municipalities should develop capacity for short-run custom production, enabling them to validate new designs. This will rapidly increase access to vetted equipment and critical network sharing with community distributed manufacturers and partners. Clear guidance and reviewed design repositories by regulatory authorities will streamline efforts to combat future pandemic waives or other surge events.

31 July 2014 in Nature Communications
Verified
Journal Article
Closed access
PDF file
KKKevin Knipe
Kevin Knipe
AMAlbert Manero
Albert Manero
SSSanna F. Siddiqui
Sanna F. Siddiqui
CMCarla Meid
Carla Meid
JWJanine Wischek
Janine Wischek
SRSeetha Raghavan
Seetha Raghavan

1 September 2015 in Composites Science and Technology
Verified
Journal Article
Closed access
AMAlbert Manero
Albert Manero
JGJason Gibson
Jason Gibson
GFGregory Freihofer
Gregory Freihofer
JGJihua Gou
Jihua Gou
SRSeetha Raghavan
Seetha Raghavan

14 August 2022 in Journal of NeuroEngineering and Rehabilitation
Verified
Journal Article
Open access
PDF file
AMAlbert Manero
Albert Manero
SMShea L. McLinden
Shea L. McLinden
JSJohn Sparkman
John Sparkman
BOBjörn Oskarsson
Björn Oskarsson
Background: This study evaluated a novel control method for patients unable to independently control powered wheelchairs. Patients with amyotrophic lateral sclerosis often require a wheelchair but struggle with sufficient hand dexterity required for joystick control making them a population that needs this type of control method. Methods: The study employed a novel control mechanism, using electromyography surface sensors applied to temporalis muscles able to measure the myoelectric voltage. Pattern and magnitude control of muscle contraction allowed for steering intention recognition and were used to manipulate their power wheelchair joystick. Four patients ages 51 to 69, two female and two male with amyotrophic lateral sclerosis, conducted Wheelchair Skills Test developed by Dalhousie University and were surveyed on the experience’s Clinical Global Impression of Change. Results: Findings showed independent steering was capable for patients without hand function and provided recommendations for improved human-machine interface. All patients demonstrated the ability to engage the system, with varying precision, for driving their wheelchair in a controlled environment. Conclusions: Three patients in the pilot trial reported the highest score of clinical global impression of change, all of whom had lost independent control of their wheelchair joystick. Patient four retained impaired hand dexterity for joystick control and reported negative impression of change, comparatively. Feedback from the study will be leveraged to improve training outcomes. Trial registration Subjects provided signed informed consent according to the Declaration of Helsinki to enter the study that was approved by the Mayo Clinic Institutional Review Board in Rochester, Minnesota. The study is registered on ClinicalTrials.gov under identifier NCT04800926 as of March 14, 2021 retrospectively registered.

1 August 2017 in Surface and Coatings Technology
Verified
Journal Article
Closed access
AMAlbert Manero
Albert Manero
ASAlex Selimov
Alex Selimov
QFQuentin Fouliard
Quentin Fouliard
KKKevin Knipe
Kevin Knipe
JWJanine Wischek
Janine Wischek
SRSeetha Raghavan
Seetha Raghavan